Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease

Journal of Thoracic and Cardiovascular Surgery

Volumn 103, Issue 1, 1992, Pages 87-97

  Turner Gomes, S O ^a   Andrew, M ^a   Coles, J ^a   Trusler, G A ^a   Williams, W G ^a   Rabinovitch, M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; VON WILLEBRAND FACTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; HEART SEPTUM DEFECT; HEMODYNAMICS; HUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0026584046     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)35070-6     Document Type: Article

References (52)

1. Rabinovitch M Keane JF Norwood WI Castaneda AR Reid L Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects Circulation 69 1984 655 667
2. Dobell ARC Trusler GA Smallhorn JF Williams WG Atrial thrombi after the Fontan operation Ann Thorac Surg 42 1986 664 667
3. Fontan F Baudet E Surgical repair of tricuspid atresia Thorax 26 1971 240 248
4. Bick RL Hemostatic defects associated with cardiac surgery, prosthetic devices and other extracorporeal circuits Semin Thromb Hemost 11 1985 249 280
5. Addonizio VP Jr Smith JB Strauss JF III Colman RW Edmunds LH Jr Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator J T horac C ardiovasc S urg 79 1980 91 96
6. Meri S Aronen M Leijala M Complement activation during cardiopulmonary bypass in children Complement 5 1988 46 54
7. Salama A Hugo F Bhakdi S Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass N Engl J Med 318 1988 408 414
8. Auler-Junior JOC Saldiva PHN Pulmonary structure and extravascular lung water after cardiopulmonary bypass Braz J Med Biol Res 19 1986 707 714
9. Dauber IM Whitman G Welsh CH Johnston M Harken A Weil JV Partial cardiopulmonary bypass causes pulmonary and coronary vascular injury evident as increased permeability Circulation 76 Pt 2 1987 IV49
10. Rabinovitch M Bothwell T Hayakawa BN Pulmonary arterial endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: a correlation of light with scanning electron microscopy and transmission electron microscopy Lab Invest 55 1986 632 653
11. Rabinovitch M Andrew M Thorn H Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects Circulation 76 1987 1043 1052
12. Jaffe EA Physiologic functions of normal endothelial cells Ann N Y Acad Sci 454 1985 279 291
13. Hattori R Hamilton KK McEver RP Sims PJ Complement C5b-9 stimulates von Willebrand factor secretion from human endothelium Circulation 78 1988 11 117
14. Holt JC Niewiarowski S Biochemistry of alpha granule proteins Semin Hematol 22 1985 151 163
15. Benveniste J Paf-Acether (Platelet-activating factor) Adv Prostaglandin Thromboxane Leukotriene Res 13 1985 11 18
16. Prestcott SM Zimmerman GA McIntyre TM Human endothelial cells in culture produce platelet activating factor (l-alkyl-2-acetyl-sn-glycero-3 phosphocholine) when stimulated with thrombin Proc Natl Acad Sci U S A 81 1984 3534 3538
17. Mammen EF Koets MH Washington BC Hemotasis changes during cardiopulmonary bypass surgery Semin Thromb Hemost 11 1985 281 292
18. Rosenberg RD Bauer KA Thrombosis in inherited deficiencies of antithrombin, protein C and protein S Hum Pathol 18 1987 253 262
19. Proctor RR Rapaport SI The partial thromboplastin time with kaolin: a simple screening test for first stage plasma clotting factor deficiencies Am J Clin Pathol 36 1961 212 219
20. Laurell CB Antigen-antibody crossed electrophoresis Anal Biochem 10 1965 358 361
21. Zimmerman TS Hoyer LW Dickson L Edgington TS Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis J Lab Clin Med 86 1975 152 159
22. Weiss HJ Hoyer LW Rickles FR Varman A Rogers J Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation: relationship to factor VIII procoagulant activity and antigen content J Clin Invest 52 1973 2708 2716
23. Ruggeri ZM Zimmerman TS The complex multimeric composition of factor VIII: von Willebrand factor Blood 57 1981 1140 1143
24. Mitchell GA Hudson PM Huseby RM Pochron SP Gargiulo RJ Fluorescent substrate assay for antithrombin III Thromb Res 12 1978 219 225
25. Comp PC Nixon RR Esmon CT Determination of functional levels of protein C, and antithrombotic protein, using thrombin-thrombomodulin complex Blood 63 1984 15 21
26. Comp PC Doray D Palton D Esmon CT An abnormal plasma distribution of protein S occurs in functional protein S deficiency Blood 67 1986 504 508
27. Grandel KE Farr RS Wanderer AA Eisenstadt TC Wasserman SI Association of platelet-activating factor with primary acquired cold urticaria N Engl J Med 313 1985 405 409
28. Heath D Edwards JE The pathology of hypertensive pulmonary vascular disease Circulation 18 1958 533 547
29. Rabinovitch M Haworth SG Castaneda AR Nadas AS Reid LM Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease Circulation 58 1978 1107 1122
30. Sokal RR Rohlf FJ Biometry The principles and practice of statistics in biological research 2nd ed. 1969 W. Freeman New York
31. Gill JC Wilson AD Endres-Brooks J Montgomery RR Loss of largest von Willebrand factor multimers from the plasma of patients with congenital heart defects Blood 67 1986 758 761
32. Kunicki TJ Montgomery RR Schullek J Cleavage of human von Willebrand factor by platelet calcium-activated protease Blood 65 1985 352 356
33. Stibbe J Effect of exercise on factor VIII complex: proportional increase of ristocetin cofactor (von Willebrand factor) and FVIII-AGN but disproportional increase of FVI-II-AHF Thromb Res 10 1977 163 168
34. Lombardi R Mannucci PM Seghatchian MJ Garcia VV Coppola R Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration Br J Haematol 49 1981 61 68
35. Salzman EW Weinstein MJ Weintraub RM Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double blind randomized trial N Engl J Med 314 1986 1402 1406
36. Czer LS Bateman TM Gray RJ Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin J Am Coll Cardiol 9 1987 1139 1147
37. Seear M Wadsworth L Scheps S The effect of DDAVP on postoperative blood loss in children Blood 70 1987 380A
38. Rocha E Llorens R Paramo JA Arcas R Cuesta B Trenor AM Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 77 1988 1319 1323
39. Weinstein M Ware JA Troll J Salzman E Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate Blood 71 1988 1648 1655
40. Ruggeri ZM Mannucci PM Lombardi R Federici AB Zimmerman TS Multimeric composition of Factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes Blood 59 1982 1272 1278
41. Martin WJ II Neutrophils kill endothelial cells by a hydrogen peroxide-dependent pathway: an in vitro model of neutrophil-mediated lung injury Am Rev Respir Dis 130 1984 209 213
42. Halonen M Palmer JD Lohman IC McManus LM Pinckard RN Respiratory and circulatory alterations induced by acetyl gylceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit Am Rev Respir Dis 124 1981 416 421
43. Ohar JA Pyle JA Hyers TM Webster RO AGEPC-induced pulmonary vascular injury—a rabbit model of pulmonary hypertension Am Rev Respir Dis 133 1986 159A
44. McIntyre TM Zimmerman GA Satoh K Prestcott SM Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate J Clin Invest 76 1985 271 280
45. Marcum JA McKenney JB Rosenberg RD Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium J Clin Invest 74 1984 341 350
46. Knot EAR Cate ten JW Drijfhout HR Kahle LH Tytgat GN Antithrombin III metabolism in patients with liver disease J Clin Pathol 37 1984 523 530
47. Kauffman RH Veltkamp JJ Tilburg van NH Es van LA Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome Am J Med 65 1978 607 613
48. Knot EAR Jong de E Cate ten JW Gie LK Royen van EA Antithrombin III: biodistribution in healthy volunteers Thromb Hemost 58 1987 1008 1011
49. Wardlow ML Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography J Chromatogr 342 1985 380 384
50. Ardlie NA Packham MA Mustard JF Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets Br J Haematol 19 1970 7 17
51. Hannahan DJ Platelet-activating factor: isolation, identification and assay Methods Biochem Anal 31 1986 195 219
52. Pinckard RN Farr RS Hanahan J Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils J Immunol 123 1979 1847 1857